Transcatheter aortic valve implantation versus surgical aortic valve replacement: A Systematic review and meta-analysis

Annals of Internal Medicine

Volumn 165, Issue 5, 2016, Pages 334-344

  Gargiulo, Giuseppe ^a   Sannino, Anna ^b   Capodanno, Davide ^c   Barbanti, Marco ^c   Buccheri, Sergio ^c   Perrino, Cinzia ^a   Capranzano, Piera ^c   Indolfi, Ciro ^d   Trimarco, Bruno ^a   Tamburino, Corrado ^c   Esposito, Giovanni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b BAYLOR RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CATANIA   (Italy)

^d UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ATRIAL FIBRILLATION; BLEEDING; CLINICAL OUTCOME; DATA BASE; DISEASE REGISTRY; FOLLOW UP; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; NEW-ONSET ATRIAL FIBRILLATION; OUTCOME ASSESSMENT; PACEMAKER IMPLANTATION; PARAVALVULAR LEAK; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SURGICAL MORTALITY; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; ADULT; ADVERSE EFFECTS; AORTIC VALVE STENOSIS; CAUSE OF DEATH; COMPARATIVE EFFECTIVENESS; HEART VALVE REPLACEMENT; MORTALITY; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME;

ADULT; AORTIC VALVE STENOSIS; CAUSE OF DEATH; COMPARATIVE EFFECTIVENESS RESEARCH; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84986000954     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M16-0060     Document Type: Review

References (60)

1. Holmes DR Jr, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012; 59:1200-54. [PMID: 22300974] doi:10.1016/j.jacc.2012.01.001.
2. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baró n-Esquivias G, Baumgartner H, et al; Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC). Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33:2451-96. [PMID: 22922415] doi:10.1093/eurheartj/ehs109.
3. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364:2187-98. [PMID: 21639811] doi:10.1056/NEJMoa1103510.
4. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686-95. [PMID: 22443479] doi:10.1056/NEJMoa1200384.
5. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al; PARTNER 1 trial investigators. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): A randomised controlled trial. Lancet. 2015;385:2477-84. [PMID: 25788234] doi:10.1016/S0140-6736(15)60308-7.
6. Adams DH, Popma JJ, Reardon MJ, Yakubov SJ, Coselli JS, Deeb GM, et al; U.S. CoreValve Clinical Investigators. Transcatheter aorticvalve replacement with a self-expanding prosthesis. N Engl J Med. 2014;370:1790-8. [PMID: 24678937] doi:10.1056/NEJMoa14005907.
7. Reardon MJ, Adams DH, Kleiman NS, Yakubov SJ, Coselli JS, Deeb GM, et al. 2-year outcomes in patients undergoing surgical or self-expanding transcatheter aortic valve replacement. J Am Coll Cardiol. 2015;66:113-21. [PMID: 26055947] doi:10.1016/j.jacc.2015.05.017.
8. Deeb GM, Reardon MJ, Chetcuti S, Patel HJ, Grossman PM, Yakubov SJ, et al; CoreValve US Clinical Investigators. Three-year outcomes in high-risk patients who had surgical or transcatheter aortic valve replacement. J Am Coll Cardiol. 2016. [PMID: 27050187] doi:10.1016/j.jacc.2016.03.506.
9. Thyregod HG, Steinbrü chel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J AmColl Cardiol. 2015;65:2184-94. [PMID: 25787196] doi:10.1016/j.jacc.2015.03.014.
10. Søndergaard L. 2-year results of the all-comers randomized Nordic aortic valve intervention (NOTION) trial comparing transcatheter versus surgical valve implantation. Presented at EuroPCR, Paris, France, 19-22 May 2015. Accessed at www.pcronline.com/Lectures/2015/2-year-results-from-an-all-comers-randomised-clinical-trial-comparing-transcatheter-with-surgical-aortic-valve-replacement-in-patients-with-aortic-valve-stenosis on 22 May 2015.
11. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al; PARTNER 2 Investigators. Transcatheter or surgical aorticvalve replacement in intermediate-risk patients. N Engl J Med. 2016; 374:1609-20. [PMID: 27040324] doi:10.1056/NEJMoa1514616.
12. Latib A, Maisano F, Bertoldi L, Giacomini A, Shannon J, Cioni M, et al. Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: A propensity score-matched case-control study. Am Heart J. 2012;164:910-7. [PMID: 23194492] doi:10.1016/j.ahj.2012.09.005.
13. Osnabrugge RL, Head SJ, Genders TS, Van Mieghem NM, De Jaegere PP, van der Boon RM, et al. Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients. Ann Thorac Surg. 2012;94:1954-60. [PMID: 22959568] doi:10.1016/j.athoracsur.2012.07.002.
14. Piazza N, Kalesan B, van Mieghem N, Head S, Wenaweser P, Carrel TP, et al. A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients. JACC Cardiovasc Interv. 2013;6: 443-51. [PMID: 23702009] doi:10.1016/j.jcin.2013.01.136.
15. Schymik G, Heimeshoff M, Bramlage P, Herbinger T, Wü rth A, Pilz L, et al. A comparison of transcatheter aortic valve implantation and surgical aortic valve replacement in 1, 141 patients with severe symptomatic aortic stenosis and less than high risk. Catheter Cardiovasc Interv. 2015;86:738-44. [PMID: 25641398] doi:10.1002/ccd.25866.
16. Tamburino C, Barbanti M, D'Errigo P, Ranucci M, Onorati F, Covello RD, et al; OBSERVANT Research Group. 1-year outcomes after transfemoral transcatheter or surgical aortic valve replacement: Results from the Italian OBSERVANT study. J Am Coll Cardiol. 2015;66: 804-12. [PMID: 26271063] doi:10.1016/j.jacc.2015.06.013.
17. Thourani VH, Kodali S, Makkar RR, Herrmann HC, Williams M, Babaliaros V, et al. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: A propensity score analysis. Lancet. 2016. [PMID: 27053442] doi:10.1016/S0140-6736(16)30073-3.
18. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int J Surg. 2010;8:336-41. [PMID: 20171303] doi:10.1016/j.ijsu.2010.02.007.
19. Higgins JP, Altman DG, Gøtzsche PC, Jü ni P, Moher D, Oxman AD, et al; Cochrane Bias Methods Group. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928. [PMID: 22008217] doi:10.1136/bmj.d5928.
20. Giacoppo D, Gargiulo G, Aruta P, Capranzano P, Tamburino C, Capodanno D. Treatment strategies for coronary in-stent restenosis: systematic review and hierarchical Bayesian network meta-analysis of 24 randomised trials and 4880 patients. BMJ. 2015;351:5392. [PMID: 26537292] doi:10.1136/bmj.h5392.
21. Liao WC, Tu YK, Wu MS, Lin JT, Wang HP, Chien KL. Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis. BMJ. 2015;349:7371. [PMID: 25556126] doi:10.1136/bmj.g7371.
22. Cornell JE, Mulrow CD, Localio R, Stack CB, Meibohm AR, Guallar E, et al. Random-effects meta-analysis of inconsistent effects: A time for change. Ann Intern Med. 2014;160:267-70. [PMID: 24727843].
23. Capodanno D, Gargiulo G, Capranzano P, Mehran R, Tamburino C, Stone GW. Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10, 350 patients from five randomized clinical trials. Eur Heart J Acute Cardiovasc Care. 2016;5:253-62. [PMID: 25746943] doi:10.1177/2048872615572599.
24. Gargiulo G, Capodanno D, Sannino A, Perrino C, Capranzano P, Stabile E, et al. Moderate and severe preoperative chronic kidney disease worsen clinical outcomes after transcatheter aortic valve implantation: meta-analysis of 4992 patients. Circ Cardiovasc Interv. 2015;8:e002220. [PMID: 25652319] doi:10.1161/CIRCINTERVENTIONS.114.002220.
25. Gargiulo G, Sannino A, Capodanno D, Perrino C, Capranzano P, Barbanti M, et al. Impact of postoperative acute kidney injury on clinical outcomes after transcatheter aortic valve implantation: A meta-analysis of 5, 971 patients. Catheter Cardiovasc Interv. 2015;86: 518-27. [PMID: 25641565] doi:10.1002/ccd.25867.
26. Nielsen HH, Klaaborg KE, Nissen H, Terp K, Mortensen PE, Kjeldsen BJ, et al. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: The STACCATO trial. EuroIntervention. 2012;8:383-9. [PMID: 22581299] doi:10.4244/EIJV8I3A58.
27. Ailawadi G, LaPar DJ, Speir AM, Ghanta RK, Yarboro LT, Crosby IK, et al. Contemporary costs associated with transcatheter aortic valve replacement: A propensity-matched cost analysis. Ann Thorac Surg. 2016;101:154-60. [PMID: 26409710] doi:10.1016/j.athoracsur.2015.05.120.
28. Appel CF, Hultkvist H, Nylander E, Ahn H, Nielsen NE, Freter W, et al. Transcatheter versus surgical treatment for aortic stenosis: patient selection and early outcome. Scand Cardiovasc J. 2012;46: 301-7. [PMID: 22656069] doi:10.3109/14017431.2012.699636.
29. Biancari F, Barbanti M, Santarpino G, Deste W, Tamburino C, Gulino S, et al. Immediate outcome after sutureless versus transcatheter aortic valve replacement. Heart Vessels. 2016;31:427-33. [PMID: 25573258] doi:10.1007/s00380-014-0623-3.
30. Conradi L, Seiffert M, Treede H, Silaschi M, Baldus S, Schirmer J, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement: A propensity score analysis in patients at high surgical risk. J Thorac Cardiovasc Surg. 2012;143:64-71. [PMID: 22054662] doi:10.1016/j.jtcvs.2011.08.047.
31. D'Onofrio A, Messina A, Lorusso R, Alfieri OR, Fusari M, Rubino P, et al. Sutureless aortic valve replacement as an alternative treatment for patients belonging to the "gray zone" between transcatheter aortic valve implantation and conventional surgery: A propensitymatched, multicenter analysis. J Thorac Cardiovasc Surg. 2012;144: 1010-6. [PMID: 22974713] doi:10.1016/j.jtcvs.2012.07.040.
32. Ewe SH, Ajmone Marsan N, Pepi M, Delgado V, Tamborini G, Muratori M, et al. Impact of left ventricular systolic function on clinical and echocardiographic outcomes following transcatheter aortic valve implantation for severe aortic stenosis. Am Heart J. 2010;160: 1113-20. [PMID: 21146666] doi:10.1016/j.ahj.2010.09.003.
33. Fusari M, Bona V, Muratori M, Salvi L, Salis S, Tamborini G, et al. Transcatheter vs. surgical aortic valve replacement: A retrospective analysis assessing clinical effectiveness and safety. J Cardiovasc Med (Hagerstown). 2012;13:229-41. [PMID: 22367569] doi:10.2459/JCM.0b013e3283515c0f.
34. Guarracino F, Talini E, Landoni G, Petronio S, Giannini C, Di Bello V. Effect of aortic valve surgery on left ventricular diastole assessed by echocardiography and neuroendocrine response: percutaneousversus surgical approach. J Cardiothorac Vasc Anesth. 2010;24:25-9. [PMID: 19944626] doi:10.1053/j.jvca.2009.09.009.
35. Hannan EL, Samadashvili Z, Stamato NJ, Lahey SJ, Wechsler A, Jordan D, et al. Utilization and 1-year mortality for transcatheter aortic valve replacement and surgical aortic valve replacement in New York patients with aortic stenosis: 2011 to 2012. JACC Cardiovasc Interv. 2016;9:578-85. [PMID: 27013157] doi:10.1016/j.jcin.2015.12.022.
36. Higgins J, Ye J, Humphries KH, Cheung A, Wood DA, Webb JG, et al. Early clinical outcomes after transapical aortic valve implantation: A propensity-matched comparison with conventional aortic valve replacement. J Thorac Cardiovasc Surg. 2011;142:e47-e52. [PMID: 21592530] doi:10.1016/j.jtcvs.2011.02.045.
37. Holzhey DM, Shi W, Rastan A, Borger MA, Hä nsig M, Mohr FW. Transapical versus conventional aortic valve replacement-a propensity-matched comparison. Heart Surg Forum. 2012;15:E4-E8. [PMID: 22360904] doi:10.1532/HSF98.20111084.
38. Johansson M, Nozohoor S, Kimblad PO, Harnek J, Olivecrona GK, Sjö gren J. Transapical versus transfemoral aortic valve implantation: A comparison of survival and safety. Ann Thorac Surg. 2011;91: 57-63. [PMID: 21172486] doi:10.1016/j.athoracsur.2010.07.072.
39. Jones SG, Abdulkareem NR, Williams F, Brecker S, Jahangiri M. Outcomes of transcatheter aortic valve implantation compared to surgical aortic valve replacement following previous surgery. J Heart Valve Dis. 2013;22:204-8. [PMID: 23798209].
40. Kobrin DM, McCarthy FH, Herrmann HC, Anwaruddin S, Kobrin S, Szeto WY, et al. Transcatheter and surgical aortic valve replacement in dialysis patients: A propensity-matched comparison. Ann Thorac Surg. 2015;100:1230-6. [PMID: 26271581] doi:10.1016/j.athoracsur.2015.05.039.
41. Minutello RM, Wong SC, Swaminathan RV, Feldman DN, Kaple RK, Horn EM, et al. Costs and in-hospital outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement in commercial cases using a propensity score matched model. Am J Cardiol. 2015;115:1443-7. [PMID: 25784513] doi:10.1016/j.amjcard.2015.02.026.
42. Muneretto C, Alfieri O, Cesana BM, Bisleri G, De Bonis M, Di Bartolomeo R, et al. A comparison of conventional surgery, transcatheter aortic valve replacement, and sutureless valves in "realworld" patients with aortic stenosis and intermediate- To high-risk profile. J Thorac Cardiovasc Surg. 2015;150:1570-7. [PMID: 26384753] doi:10.1016/j.jtcvs.2015.08.052.
43. Onorati F, D'Onofrio A, Biancari F, Salizzoni S, De Feo M, Agrifoglio M, et al; RECORD- & ITA-investigators. Results of surgical aortic valve replacement and transapical transcatheter aortic valve replacement in patients with previous coronary artery bypass grafting. Interact Cardiovasc Thorac Surg. 2016;22:806-12. [PMID: 26979656] doi:10.1093/icvts/ivw049.
44. Papadopoulos N, Schiller N, Fichtlscherer S, Lehmann R, Weber CF, Moritz A, et al. Propensity matched analysis of longterm outcomes following transcatheter based aortic valve implantation versus classic aortic valve replacement in patients with previous cardiac surgery. J Cardiothorac Surg. 2014;9:99. [PMID: 24915763] doi:10.1186/1749-8090-9-99.
45. Santarpino G, Pfeiffer S, Jessl J, Dell'Aquila A, Vogt F, von Wardenburg C, et al. Clinical outcome and cost analysis of sutureless versus transcatheter aortic valve implantation with propensity score matching analysis. Am J Cardiol. 2015;116:1737-43. [PMID: 26433277] doi:10.1016/j.amjcard.2015.08.043.
46. Stö hr R, Dohmen G, Herpertz R, Brehmer K, Aktug O, Koos R, et al. Thirty-day outcome after transcatheter aortic valve implantation compared with surgical valve replacement in patients with high-risk aortic stenosis: A matched comparison. Coron Artery Dis. 2011;22: 595-600. [PMID: 22009042] doi:10.1097/MCA.0b013e32834d335e.
47. Thakkar B, Patel A, Mohamad B, Patel NJ, Bhatt P, Bhimani R, et al. Transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with cirrhosis. Catheter Cardiovasc Interv. 2016;87:955-62. [PMID: 26699085] doi:10.1002/ccd.26345.
48. Thongprayoon C, Cheungpasitporn W, Srivali N, Harrison AM, Gunderson TM, Kittanamongkolchai W, et al. AKI after transcatheter or surgical aortic valve replacement. J Am Soc Nephrol. 2015. [PMID: 26487562].
49. Walther T, Schuler G, Borger MA, Kempfert J, Seeburger J, Rü ckert Y, et al. Transapical aortic valve implantation in 100 consecutive patients: comparison to propensity-matched conventional aortic valve replacement. Eur Heart J. 2010;31:1398-403. [PMID: 20233788] doi:10.1093/eurheartj/ehq060.
50. Wendt D, Al-Rashid F, Kahlert P, El-Chilali K, Demircioglu E, Neuhä user M, et al. Conventional aortic valve replacement or transcatheter aortic valve implantation in patients with previous cardiac surgery. J Cardiol. 2015;66:292-7. [PMID: 25975735] doi:10.1016/j.jjcc.2015.04.003.
51. Zweng I, Shi WY, Palmer S, MacIsaac A, Whitbourn R, Davis P, et al. Transcatheter versus surgical aortic valve replacement in highrisk patients: A propensity-score matched analysis. Heart Lung Circ. 2016. [PMID: 26907618] doi:10.1016/j.hlc.2016.01.005.
52. Blackstone EH, Suri RM, Rajeswaran J, Babaliaros V, Douglas PS, Fearon WF, et al. Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: A placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation. 2015;131:1989-2000. [PMID: 25832034] doi:10.1161/CIRCULATIONAHA.114.012525.
53. Cao C, Liou KP, Pathan FK, Virk S, McMonnies R, Wolfenden H, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement: meta-analysis of clinical outcomes and costeffectiveness. Curr Pharm Des. 2016;22:1965-77. [PMID: 26891807].
54. Cao C, Ang SC, Indraratna P, Manganas C, Bannon P, Black D, et al. Systematic review and meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Ann Cardiothorac Surg. 2013;2:10-23. [PMID: 23977554] doi:10.3978/j.issn.2225-319X.2012.11.09.
55. Nagaraja V, Raval J, Eslick GD, Ong AT. Transcatheter versus surgical aortic valve replacement: A systematic review and metaanalysis of randomised and non-randomised trials. Open Heart. 2014;1:e000013. [PMID: 25332780] doi:10.1136/openhrt-2013-000013.
56. Panchal HB, Ladia V, Desai S, Shah T, Ramu V. A meta-analysis of mortality and major adverse cardiovascular and cerebrovascular events following transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis. Am J Cardiol. 2013;112:850-60. [PMID: 23756547] doi:10.1016/j.amjcard.2013.05.015.
57. Takagi H, Niwa M, Mizuno Y, Goto SN, Umemoto T; All- Literature Investigation of Cardiovascular Evidence (ALICE) Group. A meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement. Ann Thorac Surg. 2013;96:513-9. [PMID: 23816417] doi:10.1016/j.athoracsur.2013.04.049.
58. Kondur A, Briasoulis A, Palla M, Penumetcha A, Mallikethi-Reddy S, Badheka A, et al. Meta-analysis of transcatheter aortic valve replacement versus surgical aortic valve replacement in patients with severe aortic valve stenosis. Am J Cardiol. 2016;117:252-7. [PMID: 26639040] doi:10.1016/j.amjcard.2015.10.034.
59. Amat-Santos IJ, Dahou A, Webb J, Dvir D, Dumesnil JG, Allende R, et al. Comparison of hemodynamic performance of the balloonexpandable SAPIEN 3 versus SAPIEN XT transcatheter valve. Am J Cardiol. 2014;114:1075-82. [PMID: 25132330] doi:10.1016/j.amjcard.2014.07.019.
60. Manoharan G, Walton AS, Brecker SJ, Pasupati S, Blackman DJ, Qiao H, et al. Treatment of symptomatic severe aortic stenosis with a novel resheathable supra-annular self-expanding transcatheter aortic valve system. JACC Cardiovasc Interv. 2015;8:1359-67. [PMID: 26315740] doi:10.1016/j.jcin.2015.05.015.